How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)
@article{TLCR41998,
author = {Bing Xia and Misako Nagasaka and Viola W. Zhu and Sai-Hong Ignatius Ou and Ross A. Soo},
title = {How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)},
journal = {Translational Lung Cancer Research},
volume = {9},
number = {6},
year = {2020},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/41998}
}